FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2761247596> ?p ?o ?g. }

• W2761247596 endingPage "1096" @default.
• W2761247596 startingPage "1090" @default.
• W2761247596 abstract "OBJECTIVE: To evaluate the benefits and harms of discontinuation of oxytocin after the active phase of labor is reached. DATA SOURCES: Electronic databases (ie, MEDLINE, Scopus, ClinicalTrials.gov, EMBASE, ScienceDirect, the Cochrane Library at the CENTRAL Register of Controlled Trials, Scielo) were searched from their inception until April 2017. METHODS OF STUDY SELECTION: We included all randomized controlled trials comparing discontinuation (ie, intervention group) and continuation (ie, control group) of oxytocin infusion after the active phase of labor is reached, either after induction or augmentation of labor. Discontinuation of oxytocin infusion was defined as discontinuing oxytocin infusion when the active phase of labor was achieved. Continuation of oxytocin infusion was defined as continuing oxytocin infusion until delivery. Only trials in singleton gestations with vertex presentation at term were included. The primary outcome was the incidence of cesarean delivery. TABULATION, INTEGRATION, AND RESULTS: Nine randomized controlled trials, including 1,538 singleton gestations, were identified as relevant and included in the meta-analysis. All nine trials included only women undergoing induction of labor. In the discontinuation group, if arrest of labor occurred, usually defined as no cervical dilation in 2 hours or inadequate uterine contractions for 2 hours or more, oxytocin infusion was restarted. Women in the control group had oxytocin continued until delivery usually at the same dose used at the time the active phase was reached. Women who were randomized to have discontinuation of oxytocin infusion after the active phase of labor was reached had a significantly lower risk of cesarean delivery (9.3% compared with 14.7%; relative risk 0.64, 95% CI 0.48–0.87) and of uterine tachysystole (6.2% compared with 13.1%; relative risk 0.53, 95% CI 0.33–0.84) compared with those who were randomized to have continuation of oxytocin infusion until delivery. Discontinuation of oxytocin infusion was associated with an increase in the duration of the active phase of labor (mean difference 27.65 minutes, 95% CI 3.94–51.36). CONCLUSION: In singleton gestations with cephalic presentation at term undergoing induction, discontinuation of oxytocin infusion after the active phase of labor at approximately 5 cm is reached reduces the risk of cesarean delivery and of uterine tachysystole compared with continuous oxytocin infusion. Given this evidence, discontinuation of oxytocin infusion once the active stage of labor is established in women being induced should be considered as an alternative management plan." @default.
• W2761247596 created "2017-10-20" @default.
• W2761247596 creator A5003499186 @default.
• W2761247596 creator A5004026496 @default.
• W2761247596 creator A5011213012 @default.
• W2761247596 creator A5016197567 @default.
• W2761247596 creator A5034488702 @default.
• W2761247596 creator A5037750648 @default.
• W2761247596 creator A5053447159 @default.
• W2761247596 creator A5057891228 @default.
• W2761247596 creator A5074270038 @default.
• W2761247596 date "2017-11-01" @default.
• W2761247596 modified "2023-10-18" @default.
• W2761247596 title "Discontinuing Oxytocin Infusion in the Active Phase of Labor" @default.
• W2761247596 cites W1944178277 @default.
• W2761247596 cites W1978748770 @default.
• W2761247596 cites W1991541930 @default.
• W2761247596 cites W1997157458 @default.
• W2761247596 cites W2047848871 @default.
• W2761247596 cites W2058282548 @default.
• W2761247596 cites W2064547610 @default.
• W2761247596 cites W2069888432 @default.
• W2761247596 cites W2078418986 @default.
• W2761247596 cites W2091856364 @default.
• W2761247596 cites W2149626748 @default.
• W2761247596 cites W2290194819 @default.
• W2761247596 cites W2410221883 @default.
• W2761247596 cites W2440606838 @default.
• W2761247596 cites W2468996569 @default.
• W2761247596 cites W2560228928 @default.
• W2761247596 cites W2562068681 @default.
• W2761247596 cites W2589401411 @default.
• W2761247596 cites W2591018516 @default.
• W2761247596 cites W2605560929 @default.
• W2761247596 cites W4235489569 @default.
• W2761247596 cites W4246380242 @default.
• W2761247596 doi "https://doi.org/10.1097/aog.0000000000002325" @default.
• W2761247596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29016497" @default.
• W2761247596 hasPublicationYear "2017" @default.
• W2761247596 type Work @default.
• W2761247596 sameAs 2761247596 @default.
• W2761247596 citedByCount "44" @default.
• W2761247596 countsByYear W27612475962017 @default.
• W2761247596 countsByYear W27612475962018 @default.
• W2761247596 countsByYear W27612475962019 @default.
• W2761247596 countsByYear W27612475962020 @default.
• W2761247596 countsByYear W27612475962021 @default.
• W2761247596 countsByYear W27612475962022 @default.
• W2761247596 countsByYear W27612475962023 @default.
• W2761247596 crossrefType "journal-article" @default.
• W2761247596 hasAuthorship W2761247596A5003499186 @default.
• W2761247596 hasAuthorship W2761247596A5004026496 @default.
• W2761247596 hasAuthorship W2761247596A5011213012 @default.
• W2761247596 hasAuthorship W2761247596A5016197567 @default.
• W2761247596 hasAuthorship W2761247596A5034488702 @default.
• W2761247596 hasAuthorship W2761247596A5037750648 @default.
• W2761247596 hasAuthorship W2761247596A5053447159 @default.
• W2761247596 hasAuthorship W2761247596A5057891228 @default.
• W2761247596 hasAuthorship W2761247596A5074270038 @default.
• W2761247596 hasConcept C126322002 @default.
• W2761247596 hasConcept C131872663 @default.
• W2761247596 hasConcept C141071460 @default.
• W2761247596 hasConcept C168563851 @default.
• W2761247596 hasConcept C2776176026 @default.
• W2761247596 hasConcept C2776478404 @default.
• W2761247596 hasConcept C2778715236 @default.
• W2761247596 hasConcept C2780802667 @default.
• W2761247596 hasConcept C42219234 @default.
• W2761247596 hasConcept C71924100 @default.
• W2761247596 hasConceptScore W2761247596C126322002 @default.
• W2761247596 hasConceptScore W2761247596C131872663 @default.
• W2761247596 hasConceptScore W2761247596C141071460 @default.
• W2761247596 hasConceptScore W2761247596C168563851 @default.
• W2761247596 hasConceptScore W2761247596C2776176026 @default.
• W2761247596 hasConceptScore W2761247596C2776478404 @default.
• W2761247596 hasConceptScore W2761247596C2778715236 @default.
• W2761247596 hasConceptScore W2761247596C2780802667 @default.
• W2761247596 hasConceptScore W2761247596C42219234 @default.
• W2761247596 hasConceptScore W2761247596C71924100 @default.
• W2761247596 hasIssue "5" @default.
• W2761247596 hasLocation W27612475961 @default.
• W2761247596 hasOpenAccess W2761247596 @default.
• W2761247596 hasPrimaryLocation W27612475961 @default.
• W2761247596 hasRelatedWork W1997157458 @default.
• W2761247596 hasRelatedWork W2149626748 @default.
• W2761247596 hasRelatedWork W2328237380 @default.
• W2761247596 hasRelatedWork W2347139510 @default.
• W2761247596 hasRelatedWork W2410221883 @default.
• W2761247596 hasRelatedWork W2416363850 @default.
• W2761247596 hasRelatedWork W2567390004 @default.
• W2761247596 hasRelatedWork W2761247596 @default.
• W2761247596 hasRelatedWork W4237346979 @default.
• W2761247596 hasRelatedWork W4320726508 @default.
• W2761247596 hasVolume "130" @default.
• W2761247596 isParatext "false" @default.
• W2761247596 isRetracted "false" @default.
• W2761247596 magId "2761247596" @default.
• W2761247596 workType "article" @default.